PALS
Paragon extinguishes $794,201.40 in debt by issuing 256,194 shares at $3.10 each.
Paragon nearly doubled revenue in Q2, but only headline sales are disclosed.
Operational growth claims outpace hard evidence; financial impact remains unproven.
Appointment of a new executive brings experience, but no operational or financial data disclosed.
Paragon swaps $2.35M debt for shares, but offers no operational or financial clarity.
This is a resume announcement, not an investable signal—no financials, just executive credentials.
This is a straightforward debt-for-equity swap with minimal hype and limited investor signal.
All promise, no proof—wait for hard numbers before considering TSXV:PALS.
Revenue is rising, but most growth claims are still just projections, not proven results.
Big promises, little hard data—wait for proof before betting on Paragon Advanced Labs.
This is a routine management hire with no hard evidence of business impact yet.